Andrew Slimmon, Morgan Stanley Investment Management senior portfolio manager, joins 'Squawk Box' to discuss the latest ...
Morgan Stanley (MS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over ...
In a report released today, Betsy Graseck from Morgan Stanley maintained a Buy rating on Goldman Sachs Group (GS – Research Report), with a ...
Morgan Stanley says it's bullish on medtech in 2025 and upgraded Intuitive Surgical (ISRG), Tandem (TNDM), Stryker (SYK), ...
Perhaps better late than never, Morgan Stanley has jumped on board the U.S. train — moving its rating on U.S. stocks to overweight, and targeting 6,500 at the end of 2025, compared to a June ...
It’s extremely difficult to predict short-term moves in the market with any accuracy. But the research, analysis, and ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on C4 Therapeutics (CCCC – Research Report). The ...
The S&P 500 has delivered a median return of +1.5% during this month over the past 45 years, with positive results occurring ...
Investing.com - Morgan Stanley (NYSE:MS) has revised its stance on the solar energy space, downgrading three stocks from Equal Weight to Underweight. The downgrades, targeting SolarEdge (NASDAQ ...
Morgan Stanley analyst Keith Weiss noted that cybersecurity remains a top spending priority for organizations globally.